Introduction
The concept of prosthesis-patient mismatch was introduced in 1978. [1] PPM occurs when the effective orifice area (EOA) of a prosthesis is too small for the patient's body size, resulting in excessively high postoperative valve gradients. [2] Independent researchers evaluating valve performance in vivo by echocardiography have underlined the overestimation of EOA in tables [3, 4] issued by valve manufacturers (based on in-vitro testing) [5, 6] and this has resulted in revised valve specifications. [7] Valve design has evolved from intra-annular implantation where the internal orifice diameter is smaller than the tissue annular diameter (TAD) to the introduction of supra-annular implantation where these diameters are equivalent. [8] This feature allows for International Cardiovascular Forum Journal 11 (2017) DOI: 10.17987/icfj.v11i0.432 supra-annular implantation of a larger valve for a fixed TAD, often of the magnitude of one valve size. Various additional design features such as the TopHat design,[4] a lower-profile sewing ring and external mounting of pericardial tissue contribute to a larger EOA. [9] The improvements in EOA are based on the premise that inferior haemodynamics result in suboptimal clinical outcomes. Studies have linked PPM with persistent left ventricular hypertrophy, diastolic dysfunction and curtailed functional improvement. [10] Late cardiac complications [11] and accelerated degeneration of bioprostheses have also been reported. [12] However, in the setting of advancing age, the combined effects of these factors on survival remains unclear. [13, 14] Although age undoubtedly increases early and late mortality after aortic valve replacement, the direct effect of mismatch remains debatable. [15] [16] [17] We studied the effect of the interaction of age and mismatch as well as the influence of iEOA on long-term survival both as a continuous variable, and as a categorical determinant of moderate or severe PPM. , and was calculated according to published data on valve EOA derived from independent researchers' postoperative echocardiographic studies (table 3) .
Methods

Statistical Methods
The student's t-test was used to compare age groups with or without PPM. The Cox proportional hazard model was used to study the impact of age, iEOA and PPM category on long-term survival. Survival analysis was performed using the facilities of the Statistical Package for Social Sciences (SPSS, Inc, Chicago, IL) by using both a non-parametric approach (Kaplan-Meier estimates) and semi-parametric approach (Cox regression analysis). The Log-Rank (Mantel-Cox) test was used to determine whether the Kaplan Meier survival curves for different age-groups differed significantly at the 0.05 level.
Results
Baseline characteristics and postoperative complications in patients without or with PPM did not differ, except for logistic/ EuroSCORE risk, which was affected by age (table 1). Survival was also plotted and analysed in relation to operative date, in five-year quartiles (figure 2). There was no influence on survival and the incidence of PPM within these quartiles was similar (p = 0.965) ( figure 3) . Mismatch was present in 167 patients and was more prevalent in younger patients. In fact, the mean age of patients with mismatch (63.35±10.61) was 2.52 years lower than their counterparts with no mismatch (65.87±11.69) and this difference is significant (p=0.016) (figure 4).
There was no correlation between PPM and perioperative mortality. There were 11 early deaths (1.9%), and of these, 10 patients had no PPM and one had moderate PPM. Seven patients who died underwent concomitant coronary grafting and 8 were over 70 years old, both recognized risk factors for increased perioperative mortality.
Survival probability was significantly affected by patient's age with the hazard of dying increasing by around 7.3% for every incremental year. In patients with severe and moderate mismatch the hazards of dying were respectively 70.3% and 31.2% higher compared to patients with no PPM, but the increase was not statistically significant. In patients with mismatch the hazards of dying were 86.5% higher for 19mm valves, 68.7% for 21mm valves and 13.7% for 23mm valves compared to 25mm valves. These hazard ratios are not significant mainly because the incidence of mismatch was low, particularly for the larger valves. (table 6) . When iEOA was analysed as a continuous parameter rather than a categorical parameter, a higher iEOA was associated with a significantly reduced hazard ratio of dying. The chance of survival increased by 8.8% for every 0.1 unit increment in iEOA (table 7).
In conclusion, age was a significant predictor of long-term survival whereas prosthesis-patient mismatch failed to exert a statistically significant effect. This situation applied for both moderate and severe mismatch and for all valve sizes used. In contrast long-term survival was affected by iEOA when this was analyzed as a continuous variable.
Discussion
Cardiac-related mortality was shown to be increased by prosthesis-patient mismatch in a meta-analysis of 34 observational studies published in 2012. [26] This analysis included a number of studies that failed to demonstrate a significant effect of PPM, amongst which were one study [27] with a longer mean follow-up (9.1 vs. 7.8 years) and a second [28] with a comparable follow-up (median of 7.3 vs. 7.3 years) to our study. Both these studies failed to show a significant effect on survival, raising the possibility that a longer follow-up may be salient. The authors stressed the value of preventing PPM, particularly in younger patients in whom long-term survival may be impacted to a greater extent.
The incidence of common postoperative complications was similar in patients with or without PPM. Certain complications have been shown, by multivariate analysis, to affect long-term outcome. [29] In this study risk stratification was higher by logistic (p=0.046) and additive EuroSCORE (p=0.037) in patients without PPM because this group was older by 2.52 years, age being a contributor to the score. The incidence of mismatch is higher in younger patients and this may attenuate its effect on survival. Follow-up duration is inversely proportional to advancing age at operation. Studies with a longer follow-up have failed to demonstrate a deleterious effect of mismatch. The combined effect of a younger age and a longer follow-up may overshadow the importance of mismatch in determining long-term survival. Although mismatch leads to adverse cardiac events its effect on survival is reduced by advancing age. [29] Our results suggest that age, and its direct effect on follow-up duration, significantly affects survival whereas mismatch does not.
A long follow-up necessarily entails evolving practices including the implantation of novel valves that may significantly affect survival. Analysis of survival by operative date, in four five-year quartiles, showed no significant difference in survival in these groups.
When valve haemodynamics are translated into a continuum of iEOA a significant effect on long-term survival becomes evident. This relationship failed to reach statistical significance with mismatch because of the low incidence of moderate PPM, and the very low incidence of severe PPM. All data pertaining to valve EOA was obtained from published studies and not from our own post-operative measurements. These values should be readily available in theatre and act as a guide to the surgeon implanting an aortic prosthesis with the goal of avoiding mismatch. Our study suggests that the largest size valve with the best possible EOA should always be implanted. In extreme circumstances of a small aortic root, enlargement may be performed. However, the increased operative risk of this procedure has not been shown to benefit long-term survival. [30] 
Limitations
The data was derived from a single surgeon's practice and may not be representative of a wider population. A change in the use of certain valve models during the study period may have influenced the outcome. The low incidence of mismatch may have been a factor limiting statistical significance.
Conclusion
PPM, whether moderate or severe, did not significantly curtail long-term survival. A larger iEOA increased survival by 8.8% per 0.1 unit increase. Age exerted a significant effect on survival, reducing it by 7.3% for each incremental year.
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